Works matching IS 1470269X AND DT 2014 AND VI 14 AND IP 4


Results: 15
    1
    2

    Prospective study of EGFR intron 1 (CA)<sub>n</sub> repeats variants as predictors of benefit from cetuximab and irinotecan in chemo-refractory metastatic colorectal cancer (mCRC) patients.

    Published in:
    Pharmacogenomics Journal, 2014, v. 14, n. 4, p. 322, doi. 10.1038/tpj.2014.1
    By:
    • Loupakis, F;
    • Antoniotti, C;
    • Cremolini, C;
    • Zhang, W;
    • Yang, D;
    • Wakatsuki, T;
    • Bohanes, P;
    • Schirripa, M;
    • Salvatore, L;
    • Masi, G;
    • Ricci, V;
    • Graziano, F;
    • Ruzzo, A;
    • Benhaim, L;
    • Marmorino, F;
    • Ning, Y;
    • El-Khoueiry, R;
    • Falcone, A;
    • Lenz, H-J
    Publication type:
    Article
    3
    4
    5
    6

    Insights into the pathophysiology of catch-up compared with non-catch-up growth in children born small for gestational age: an integrated analysis of metabolic and transcriptomic data.

    Published in:
    Pharmacogenomics Journal, 2014, v. 14, n. 4, p. 376, doi. 10.1038/tpj.2014.4
    By:
    • Stevens, A;
    • Bonshek, C;
    • Whatmore, A;
    • Butcher, I;
    • Hanson, D;
    • De Leonibus, C;
    • Shaikh, G;
    • Brown, M;
    • O'Shea, E;
    • Victor, S;
    • Powell, P;
    • Settle, P;
    • Padmakumar, B;
    • Tan, A;
    • Odeka, E;
    • Cooper, C;
    • Birch, J;
    • Shenoy, A;
    • Westwood, M;
    • Patel, L
    Publication type:
    Article
    7
    8
    9
    10
    11
    12
    13
    14
    15